HK1038609A1 - Method for early diagnosis of carcinomas - Google Patents
Method for early diagnosis of carcinomasInfo
- Publication number
- HK1038609A1 HK1038609A1 HK01107321A HK01107321A HK1038609A1 HK 1038609 A1 HK1038609 A1 HK 1038609A1 HK 01107321 A HK01107321 A HK 01107321A HK 01107321 A HK01107321 A HK 01107321A HK 1038609 A1 HK1038609 A1 HK 1038609A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carcinomas
- early diagnosis
- overexpression
- cell cycle
- comprises determining
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19829473A DE19829473C2 (de) | 1998-07-01 | 1998-07-01 | Verfahren zur frühen Diagnose von Carcinomen |
PCT/DE1999/002094 WO2000001845A2 (de) | 1998-07-01 | 1999-07-01 | Verfahren zur frühen diagnose von carcinomen |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1038609A1 true HK1038609A1 (en) | 2002-03-22 |
Family
ID=7872684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01107321A HK1038609A1 (en) | 1998-07-01 | 2001-10-18 | Method for early diagnosis of carcinomas |
Country Status (23)
Country | Link |
---|---|
US (2) | US6709832B1 (xx) |
EP (1) | EP1092155B1 (xx) |
JP (1) | JP3404020B2 (xx) |
KR (1) | KR100646193B1 (xx) |
CN (1) | CN1209627C (xx) |
AT (1) | ATE230487T1 (xx) |
AU (1) | AU749769B2 (xx) |
BR (1) | BRPI9912227B8 (xx) |
CA (1) | CA2336153C (xx) |
CZ (1) | CZ292076B6 (xx) |
DE (2) | DE19829473C2 (xx) |
DK (1) | DK1092155T3 (xx) |
ES (1) | ES2190820T3 (xx) |
HK (1) | HK1038609A1 (xx) |
HU (1) | HUP0102744A2 (xx) |
IL (1) | IL140550A (xx) |
MX (1) | MXPA00012852A (xx) |
NO (1) | NO328685B1 (xx) |
PL (1) | PL198623B1 (xx) |
RU (1) | RU2217761C2 (xx) |
SK (1) | SK284056B6 (xx) |
TR (1) | TR200003903T2 (xx) |
WO (1) | WO2000001845A2 (xx) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7306926B2 (en) * | 1998-07-01 | 2007-12-11 | Mtm Laboratories Ag | Method for detecting carcinomas in a solubilized cervical body sample |
AUPP991199A0 (en) * | 1999-04-21 | 1999-05-13 | University Of Sydney, The | Methods for diagnosing pre-cancerous and cancerous conditions |
DE10006033B4 (de) * | 2000-02-10 | 2005-11-10 | Professor Dr. Magnus von Knebel Doeberitz Chirurgische Universitätsklinik Sektion für Molekulare Diagnostik und Therapie | Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen |
US20060057651A1 (en) * | 2000-12-08 | 2006-03-16 | Bowdish Katherine S | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
US7408041B2 (en) | 2000-12-08 | 2008-08-05 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
US9249229B2 (en) | 2000-12-08 | 2016-02-02 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
AUPR201500A0 (en) * | 2000-12-11 | 2001-01-11 | Biosceptre Pty Ltd | Methods for identifying pre-neoplastic and neoplastic states in mammals |
DE10063179A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern |
DE60230482D1 (de) * | 2001-01-17 | 2009-02-05 | Intreat Pty Ltd | Antikörper gegen nichtfunktionelle p 2 x 7 rezeptoren, diagnose und behandlung von krebs und anderen leiden |
EP1369694A1 (en) | 2002-04-09 | 2003-12-10 | MTM Laboratories AG | Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
DK1388734T3 (da) * | 2002-08-01 | 2004-05-03 | Mtm Lab Ag | Metode til opløsningsbaseret diagnose |
EP1422526A1 (en) * | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Method for improved diagnosis of dysplasias |
US20050266409A1 (en) * | 2003-02-04 | 2005-12-01 | Wyeth | Compositions and methods for diagnosing, preventing, and treating cancers |
WO2004076686A1 (ja) * | 2003-02-26 | 2004-09-10 | Sysmex Corporation | 細胞の検査方法 |
ATE289685T1 (de) * | 2003-08-25 | 2005-03-15 | Mtm Lab Ag | Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben |
KR20110027823A (ko) * | 2004-03-24 | 2011-03-16 | 트리패스 이미징, 인코포레이티드 | 자궁경부 질환의 검사 방법 및 조성물 |
WO2005116241A1 (ja) * | 2004-05-31 | 2005-12-08 | Sysmex Corporation | 哺乳動物細胞の性質判定方法及びこれを用いた癌の診断方法 |
EP1628135A1 (en) * | 2004-08-20 | 2006-02-22 | MTM Laboratories AG | Method for detecting medically relevant conditions in a solubilized LBC sample |
US7892750B1 (en) * | 2004-12-23 | 2011-02-22 | University Of Notre Dame Du Lac | Cathepsin E as a marker of colon cancer |
JP4766969B2 (ja) | 2005-09-14 | 2011-09-07 | シスメックス株式会社 | 組織性質判定装置 |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
KR20140091765A (ko) | 2006-01-12 | 2014-07-22 | 알렉시온 파마슈티칼스, 인코포레이티드 | Ox-2/cd200에 대한 항체 및 이들의 용도 |
JP2010505426A (ja) * | 2006-10-10 | 2010-02-25 | バイオスセプター インターナショナル リミテッド | 非機能性p2x7受容体に対する抗体を産生するハイブリドーマ |
US20100003704A1 (en) * | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
JP5111902B2 (ja) * | 2007-03-14 | 2013-01-09 | シスメックス株式会社 | 癌の診断支援装置 |
US8921114B2 (en) | 2007-08-24 | 2014-12-30 | Sysmex Corporation | Diagnosis support system for cancer, diagnosis support information providing method for cancer, and computer program product |
NZ583894A (en) | 2007-09-14 | 2013-01-25 | Biosceptre Int Ltd | Antibodies that bind to a non atp binding p2x7 receptor |
AU2008299594B2 (en) | 2007-09-14 | 2013-10-03 | Biosceptre International Limited | Purinergic (P2X) receptors in extra-cellular body fluid |
CA2729868C (en) * | 2008-07-04 | 2018-07-10 | Biosceptre International Limited | Anti- p2x7 peptides and epitopes |
JP2012526286A (ja) * | 2009-05-07 | 2012-10-25 | オンコヘルス コーポレーション | ヒトパピローマウイルス(hpv)およびhpv関連癌の初期段階および後期段階の検出、スクリーニング、および診断のための高度または≧cin2の同定 |
EP2966090B1 (en) | 2009-08-20 | 2018-10-10 | Biosceptre (Aust) Pty Ltd | Anti p2x7 receptor antibodies and fragments thereof |
ES2667003T3 (es) | 2009-12-24 | 2018-05-09 | Biosceptre (Aust) Pty Ltd | Anticuerpos para receptores P2X7 oligoméricos no funcionales |
CN102822672B (zh) | 2010-01-08 | 2015-12-09 | 安科健康公司 | 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定 |
US8900813B2 (en) | 2010-08-17 | 2014-12-02 | Medical Diagnostic Laboratories, Llc | CIP2A as a biomarker in detection of cervical cancer |
EP2613808B1 (en) | 2010-09-10 | 2017-11-08 | Biosceptre (Aust) Pty Ltd | Companion animal cancer treatments with an anti p2x7 antibody |
US9551700B2 (en) | 2010-12-20 | 2017-01-24 | Milagen, Inc. | Device and methods for the detection of cervical disease |
CA2840251C (en) | 2011-07-01 | 2023-09-12 | Biosceptre International Limited | Combination therapy of diseases that are associated with non-functional p2x7 receptor expression |
WO2013067268A1 (en) | 2011-11-03 | 2013-05-10 | Tripath Imaging, Inc. | Methods and compositions for preparing samples for immunostaining |
JP6174035B2 (ja) | 2011-11-15 | 2017-08-02 | ユニヴァーシティ・オヴ・マイアミ | ヒトパピローマウイルスを検出し頭頸部扁平上皮癌を予後予測する方法 |
US11761963B2 (en) | 2017-09-27 | 2023-09-19 | Alexion Pharmaceuticals, Inc. | Biomarker signature for predicting tumor response to anti-CD200 therapy |
WO2019234176A1 (en) | 2018-06-07 | 2019-12-12 | Universitaet Des Saarlandes | Novel biomarkers for carcinoma diagnosis |
CN108893534A (zh) * | 2018-06-26 | 2018-11-27 | 华中科技大学鄂州工业技术研究院 | 泛癌症诊断标记物 |
RU2707884C1 (ru) * | 2018-10-03 | 2019-12-02 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се | Способ ранней диагностики почечно-клеточной карциномы по наличию антител к зрительному аррестину |
FR3088640A1 (fr) | 2018-10-14 | 2020-05-22 | Smart Diagnostix Pharma | Nouveau polypeptide se liant specifiquement a la proteine p16 |
CN111257565A (zh) * | 2018-12-03 | 2020-06-09 | 上海细胞治疗集团有限公司 | 一种衰老细胞的检测试剂盒及其检测方法 |
CN113295683A (zh) * | 2021-05-24 | 2021-08-24 | 烟台海关技术中心 | 过氧化苯甲酰检测方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
US5268463A (en) * | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
DE69333043T2 (de) | 1992-10-16 | 2004-05-06 | Cold Spring Harbor Laboratory | Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen |
AU5694694A (en) * | 1992-12-02 | 1994-06-22 | Denis F. Hochstrasser | A method for detecting growing cells using translationally controlled tumor protein p21 |
US5543291A (en) * | 1993-01-29 | 1996-08-06 | Dana Farber Cancer Institute | Method of detecting carcinoma |
US6316208B1 (en) * | 1994-01-07 | 2001-11-13 | Memorial Sloan-Kettering Cancer Center | Methods for determining isolated p27 protein levels and uses thereof |
AU685627B2 (en) * | 1994-03-18 | 1998-01-22 | Myriad Genetics, Inc. | Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene |
US5763190A (en) * | 1994-09-21 | 1998-06-09 | The Trustees Of The University Of Pennsylvania | Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein |
US6033847A (en) * | 1995-02-06 | 2000-03-07 | St. Jude Children's Research Hospital | InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
US5976799A (en) | 1996-03-21 | 1999-11-02 | The Board Of Trustees Of The University Of Arkansas | Early detection of ovarian carcinoma using P16 gene products |
US5851797A (en) * | 1996-06-19 | 1998-12-22 | Regeneron Pharmaceuticals, Inc. | Tie ligand-3, methods of making and uses thereof |
US5858683A (en) * | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
WO2000024245A1 (en) * | 1998-10-28 | 2000-05-04 | President And Fellows Of Harvard College | REGULATION OF TH2 CELL ACTIVITY BY MODULATION OF NFATp AND NFAT4 ACTIVITY |
-
1998
- 1998-07-01 DE DE19829473A patent/DE19829473C2/de not_active Expired - Lifetime
-
1999
- 1999-07-01 BR BRPI9912227-8B1 patent/BRPI9912227B8/pt active IP Right Grant
- 1999-07-01 CZ CZ20004922A patent/CZ292076B6/cs not_active IP Right Cessation
- 1999-07-01 IL IL14055099A patent/IL140550A/xx not_active IP Right Cessation
- 1999-07-01 DK DK99945931T patent/DK1092155T3/da active
- 1999-07-01 SK SK2031-2000A patent/SK284056B6/sk not_active IP Right Cessation
- 1999-07-01 CN CNB998079111A patent/CN1209627C/zh not_active Expired - Lifetime
- 1999-07-01 PL PL345407A patent/PL198623B1/pl unknown
- 1999-07-01 RU RU2001102598/15A patent/RU2217761C2/ru active
- 1999-07-01 AU AU58487/99A patent/AU749769B2/en not_active Expired
- 1999-07-01 MX MXPA00012852A patent/MXPA00012852A/es active IP Right Grant
- 1999-07-01 CA CA002336153A patent/CA2336153C/en not_active Expired - Lifetime
- 1999-07-01 AT AT99945931T patent/ATE230487T1/de active
- 1999-07-01 TR TR2000/03903T patent/TR200003903T2/xx unknown
- 1999-07-01 EP EP99945931A patent/EP1092155B1/de not_active Expired - Lifetime
- 1999-07-01 HU HU0102744A patent/HUP0102744A2/hu unknown
- 1999-07-01 JP JP2000558235A patent/JP3404020B2/ja not_active Expired - Lifetime
- 1999-07-01 KR KR1020017000026A patent/KR100646193B1/ko not_active IP Right Cessation
- 1999-07-01 WO PCT/DE1999/002094 patent/WO2000001845A2/de active IP Right Grant
- 1999-07-01 DE DE59903915T patent/DE59903915D1/de not_active Expired - Lifetime
- 1999-07-01 ES ES99945931T patent/ES2190820T3/es not_active Expired - Lifetime
- 1999-07-01 US US09/743,103 patent/US6709832B1/en not_active Expired - Lifetime
-
2000
- 2000-12-28 NO NO20006681A patent/NO328685B1/no not_active IP Right Cessation
-
2001
- 2001-10-18 HK HK01107321A patent/HK1038609A1/xx not_active IP Right Cessation
-
2003
- 2003-02-20 US US10/371,883 patent/US20030152993A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL345407A1 (en) | Method for early diagnosis of carcinomas | |
HK1092219A1 (en) | Method for detecting neoplastic disorders in a solubilized body sample | |
WO2000005265A3 (en) | Anti-crr2 antibodies and methods of use therefor | |
MY138674A (en) | Radiolabeling kit and binding assay | |
EP1687283A4 (en) | PROCESS AND COMPOSITION FOR DETERMINING FK 506 | |
WO1997008318A3 (en) | Compounds and methods for treatment and diagnosis of prostate cancer | |
EP1708745A4 (en) | ANTIBODIES FOR ONCOGEN STRAINS OF HPV AND METHODS OF USE | |
WO2000008464A3 (de) | Verfahren zur bestimmung der immunabwehr des blutes sowie testkit hierfür | |
WO2000035950A3 (en) | Reagents and methods useful for detecting diseases of the breast | |
SE9604815D0 (sv) | A metod of diagnosis | |
FR2816410B1 (fr) | Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire | |
WO2002021133A3 (en) | Methods of detecting cancer based on prostasin | |
HK1044190A1 (en) | A method for identifying pre-neoplastic and/or neoplastic states in mammals | |
AU7571998A (en) | Rapid evaluation of the ratio of biological molecules | |
WO2001007471A3 (en) | Cell cycle and proliferation proteins | |
GB0004576D0 (en) | Proteins | |
AU4865997A (en) | Monoclonal antibodies against a human act and serine protease complex | |
SE0002835D0 (sv) | Method and kit for production of monoclonal antibodies | |
AU4908799A (en) | Determination of the hydrophobic pulmonary surfactant protein sp-c | |
AU2002233278A1 (en) | Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit | |
AU9437598A (en) | Method and kit for identifying interactions between proteins or peptides | |
AU5569600A (en) | Novel protein and dna thereof | |
NO992531L (no) | Fremgangsmåter ved fremstilling av rekombinant protein | |
AU4459197A (en) | Diagnosis aid and process for detecting pregnancy in ruminants | |
WO2001006226A3 (de) | Verfahren zur bestimmung der proliferationsaktivität von zellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20190630 |